Articles

A new study in JAMA Health Forum by USC Schaeffer Center experts analyzes state and federal responses to the opioid crisis amidst the pandemic. The authors find that while all states and D.C. have adopted at least one policy related to treatment access for patients suffering from opioid addiction, zero states adopted all policies important to treatment access.

Pilot funding amounts range from $25,000 to up to $45,000. An informational session on the application process will be held over zoom on Thursday, December 9, 2021, at 10:00 a.m. pacific. 

Despite its discovery nearly 100 years ago, insulin’s list price has been going up, not down. New Schaeffer Center research analyzes the flow of money across all distribution system participants—manufacturers, wholesalers, pharmacies, pharmacy benefit managers (PBMs), and health plans.

The Roybal Center for Behavioral Interventions in Aging seeks proposals for pilot projects that involve randomized controlled trials (RCTs).

Social vulnerability was also independently associated with widening disparities in county-level coverage, signaling the need for unique, targeted interventions.

The limitations of conventional approaches to value assessment are particularly clear when reflecting on our experience with the COVID-19 pandemic.

In the US health care system, payers, health systems, physicians, other clinicians, drug companies, pharmacies, and pharmacy benefit managers all earn more revenue because of administrative complexity.

USC Schaeffer study finds Federal 340B Drug Pricing Program oversight needs tightening to ensure discounts reach the right safety-net providers and patients